Alexa Fluor® 568 Anti-VPS35 抗体 [EPR11501(B)]
Alexa Fluor® 568 Anti-VPS35 antibody [EPR11501(B)]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal VPS35 antibody - conjugated to Alexa Fluor® 568.
別名を表示する
MEM3, TCCCTA00141, VPS35, Vacuolar protein sorting-associated protein 35, hVPS35, Maternal-embryonic 3, Vesicle protein sorting 35
関連する標識済み抗体及び組成の異なる製品 (8)
-
Anti-VPS35 antibody [EPR11501(B)] - BSA and Azide free
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-VPS35 antibody [EPR11501(B)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-VPS35 antibody [EPR11501(B)]
-
660 APC
APC Anti-VPS35 antibody [EPR11501(B)]
-
578 PE
PE Anti-VPS35 antibody [EPR11501(B)]
-
Anti-VPS35 antibody [EPR11501(B)]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-VPS35 antibody [EPR11501(B)]
-
HRP Anti-VPS35 antibody [EPR11501(B)]
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com